首页> 美国卫生研究院文献>Public Health Action >The referral pathway of presumptive drug-resistant tuberculosis in an urban poor setting The Philippines
【2h】

The referral pathway of presumptive drug-resistant tuberculosis in an urban poor setting The Philippines

机译:菲律宾城市贫困地区推定耐药性结核病的转诊途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Setting: Socio-economically underprivileged urban areas in the Philippines.>Objectives: To identify gaps in the referral pathway of presumptive drug-resistant tuberculosis (DR-TB) patients from initial consultation until initiation of treatment.>Design: A retrospective study in which a masterlist of presumptive multidrug-resistant TB (MDR-TB) patients registered in 18 DOTS facilities in Tondo, Manila and Payatas, Quezon City, from October 2012 to September 2013, was analysed and reviewed.>Results: Among 378 presumptive DR-TB patients identified and listed in the masterlist, 97% (368/378) were referred, of whom 90% (333/368) were screened at an MDR-TB treatment centre. Of the 368 patients, 35 (9.5%) were not screened, mainly due to loss to follow-up. Among those screened, 86.4% (288/333) were recommended for anti-tuberculosis treatment, of whom 98.2% (283/288) initiated treatment. The time between sample collection and examination was significantly longer at the laboratories of non-government organisations (NGOs) than at local government units (LGUs) (1 day vs. 0 day; P < 0.001). The time to the release of smear examination results to patients was significantly shorter at the NGOs than at the LGUs (4 days vs. 6 days; P = 0.009).>Conclusion: The development of the presumptive MDR-TB masterlist facilitated tracking of patients for diagnosis and treatment. The NGOs should reduce delays in diagnosis and the LGUs should intensify patient follow-up to ensure early initiation of treatment.
机译:>设置:菲律宾的社会经济贫困城市地区。>目标:从初步咨询中找出推定的耐药结核病(DR-TB)患者转诊途径中的差距直到开始治疗。>设计:一项回顾性研究,该研究从10月开始在马尼拉Tondo,奎松市Payatas的18个DOTS设施中登记了多药耐药性结核病(MDR-TB)推测患者名单分析并审查了2012年至2013年9月的结果。>结果:在鉴定并列入主列表的378名推定性DR-TB患者中,有97%(368/378)被转诊,其中90%(333 / 368)在耐多药结核病治疗中心进行了筛查。在368例患者中,有35例(9.5%)未接受筛查,主要是由于随访失败。在筛查的人群中,推荐86.4%(288/333)用于抗结核治疗,其中98.2%(283/288)开始抗结核治疗。在非政府组织(NGOs)的实验室中,从样本收集到检查的时间比在地方政府部门(LGUs)中的时间显着更长(1天vs. 0天; P <0.001)。 NGOs向患者发布涂片检查结果的时间比LGUs显着缩短(4天比6天; P = 0.009)。>结论:推定的MDR-结核病大师名单有助于追踪患者的诊断和治疗。非政府组织应减少诊断延迟,LGU应加强对患者的随访,以确保尽早开始治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号